Verona Pharma (NASDAQ:VRNA)'s stock has reached an unprecedented peak, setting an all-time high at $56.49. This milestone underscores a remarkable period of growth for the $4.49 billion ...
Truist Financial analyst Tobey Sommer maintained a Buy rating on Waste Management (WM – Research Report) today. The company’s shares closed ...
Operator Good day, ladies and gentlemen, and welcome to Northrop Grumman's fourth quarter 2024 conference call. Today's call ...
Silgan Holdings Inc. ( NYSE: SLGN) Q4 2024 Earnings Conference Call January 29, 2025 11:00 AM ET ...